Prurigo nodularis: A benign dermatosis derived from a persistent pruritus

Acta Dermatovenerologica Croatica

Volumn 16, Issue 1, 2008, Pages 38-44

  Vaidya, Darshan C ^a   Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Atopic dermatitis; HIV disease; Lichen simplex chronicus; Neurodermatitis; Neurohyperplasia; Prurigo nodularis

Indexed keywords

ANTIDEPRESSANT AGENT; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; BETAMETHASONE VALERATE; CALCIPOTRIOL; CAPSAICIN; CHLORPHENIRAMINE MALEATE; CORTICOSTEROID; CYCLOSPORIN; HYDROCORTISONE; HYDROXYZINE; IMMUNOMODULATING AGENT; MENTHOL; PHENOL; PIMECROLIMUS; PRAMOCAINE; PROMETHAZINE; SARNA; SEROTONIN UPTAKE INHIBITOR; TACROLIMUS; THALIDOMIDE;

ABSENCE OF SIDE EFFECTS; BEDTIME DOSAGE; CANCER PATIENT; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LOW LEVEL LASER THERAPY; NEURODERMATITIS; PATHOGENESIS; PATIENT REFERRAL; PROGNOSIS; PRURIGO NODULARIS; PRURITUS; PULSED DYE LASER; QUALITY OF LIFE; SENSORY NEUROPATHY; SIDE EFFECT; SKIN SURGERY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

DIAGNOSIS, DIFFERENTIAL; HUMANS; PRURIGO; PRURITUS;

EID: 44349132117     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Hyde JN, Montgomery FH. A practical treatise on diseases of the skin for the use of students and practitioners. Philadelphia: Lea and Febiger; 1909. p. 174-5.
2. Ständer S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007;87:291-4.
3. Lee MR, Shumack S. Prurigo nodularis: a review. Aust J Dermatol 2005;46:211-20.
4. Berth-Jones J, Smith SG, Graham-Brown RAC. Nodular prurigo responds to cyclosporine. Br J Dermatol 1995;132:795-9.
5. Schelnitz LS, Paller AS. Hodgkin's disease manifesting as prurigo nodularis. Pediatr Dermatol 1990;7:136-9.
6. Tanaka M, Aiba S, Matsumura N, Aoyama H, Tagami H. Prurigo nodularis consists of two distinct forms: early-onset atopic and late-onset atopic. Dermatology 1995;190:269-76.
7. Hogan D, Bower S, Mason SM, Mason SH. Prurigo nodularis. eMedicine. Available at: http://www.emedicine.com/derm/topic350.htm. Accessed August 30, 2007.
8. Schneider G, Driesch G, Heuft G, Evers S, Luger TA, Stander S. Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Exp Dermatol 2006;31:762-7.
9. Harris B, Harris K, Penneys NS. Demonstration by S-100 protein staining of increased numbers of nerves in the papillary dermis of patients with prurigo nodularis. J Am Acad Dermatol 1992;26:56-8.
10. Feuerman EJ, Sandbank M. Prurigo nodularis: histological and electron microscopical study. Arch Dermatol 1975;111:1472-7.
11. Doyle JA, Connolly SM, Hunziker N, Winkelmann RK. Prurigo nodularis: a reappraisal of the clinical and histologic features. J Cutan Pathol 1979;6:392-403.
12. Docrat ME. Prurigo nodularis. Curr Opin Allergy Clin Immunol 2005;18:81-2.
13. Payne R, Wilkinson JD, McKee PH, Jurecka W, Black MM. Nodular prurigo - a clinicopathological study of 46 patients. Br J Dermatol 1985;113:431-9.
14. Nowak A, Szamer B, Mikulska D. A case of prurigo nodularis Hyde in the course of chronic hepatitis B virus infection. Postepy Dermatol 1998;15:309-12.
15. Neri S, Raciti C, D'Angelo G, Ierna D, Bruno CM. Hyde's prurigo nodularis and chronic HCV hepatitis. J Hepatol 1998;28:161-4.
16. Matthews S, Cockerell C. Prurigo nodularis in HIV-infected individuals. Int J Dermatol 1998;37:401-9.
17. Perez GL, Peters MS, Reda AM, Butterfield JH, Peterson EA, Leiferman KM. Mast cells, neutrophils and eosinophils in prurigo nodularis. Arch Dermatol 1993;129:861-5.
18. Turner JD, Schwartz RA. Atopic dermatitis: a clinical challenge. Acta Dermatovenereol APA 2006;15:59-68.
19. Johansson O, Liang Y, Emtestam L. Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin - an exploration of the cause of neurohyperplasia. Arch Dermatol Res 2002;293:614-9.
20. Liang Y, Heilborn JD, Marcusson JA, Johansson O. Increased NGFr immunoreactive, dermal nerve fibers in prurigo nodularis. Eur J Dermatol 1996;6:563-7.
21. Liang Y, Marcusson JA, Johansson O. Light and electron microscopic immunohistochemical observations of p75 nerve growth factor receptor- immunoreactive dermal nerves in prurigo nodularis. Arch Dermatol Res 1999;291:14-21.
22. Nahass G, Penneys NS. Merkel cells and prurigo nodularis. J Am Acad Dermatol 1994;31:86-8.
23. Johansson O, Liang Y, Heilborn J, Marcusson J. Langerhans cells in prurigo nodularis investigated by HLA-DR and S-100 immunofluorescence double staining. J Dermatol Sci 1998;17:24-32.
24. Klecz RJ, Schwartz RA. Pruritus. Am Fam Physician 1992;45:2681-6.
25. Winhoven SM, Gawkrodger DJ. Nodular prurigo: metabolic diseases are a common association. Clin Exp Dermatol 2007;32:224-5.
26. Habif TP. Skin Disease: Diagnosis and Treatment. Toronto: Elsevier; 2005. p. 54-5.
27. Wong SS, Goh CL. Double-blind, right/left comparison of calcipotriol ointment and beta-methasone ointment in the treatment of prurigo nodularis. Arch Dermatol 2000;136:807-8.
28. Ständer S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001;44:471-8.
29. Paghdal KV, Schwartz RA. Thalidomide and its dermatologic uses. Acta Dermatovenereol Croat 2007;15:34-9.
30. Van den Broke H. Treatment of prurigo nodularis with thalidomide. Arch Dermatol 1980;116:571-2.
31. Ferrandiz C, Carrascosa JM, Just M, Bielsa I, Ribera M. Sequential combined therapy with thalidomide and narrow-band (TL01) UVB in the treatment of prurigo nodularis. Dermatology 1997;195:359-61.
32. Crouch RB, Foley PA, Ng JCH, Baker CS. Thalidomide experience of a major teaching hospital. Aust J Dermatol 2002;43:278-84.
33. Maurer T, Poncelet A, Berger T. Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected individuals. Arch Dermatol 2004;140:845-9.
34. Woo PN, Finch TM, Hindson C, Foulds IS. Nodular prurigo successfully treated with the pulsed dye laser. Br J Dermatol 2000;143:215-6.
35. Ständer S, Luger TA. Antipruritic effects of pimecrolimus and tacrolimus. Hautarzt 2003;54:413-7.